II. Epidemiology
-
Prevalence under age 18 years old
- Prehypertension: 3.4%
- Hypertension: 3.6%
-
Prevalence in Overweight or obese adolescents
- Hypertension in up to 10% of children with Obesity
- Prehypertension may be present in up to 30% of obese children (esp. boys)
III. Precautions
- Hypertension in Children is underdiagnosed
- Only 26% of patients with criteria consistent with Hypertension are formally diagnosed
- Hansen (2007) JAMA 298(8): 874-9 [PubMed]
IV. Causes
- See Hypertension Causes in Children
- Renovascular disease is most common cause in children
- Features most suggestive of Secondary Hypertension
- Hypertension under age 10 years
- Stage 2 Hypertension in Children
V. Risk Factors
-
Obesity
- Increased Body Mass Index
- Increased abdominal circumference
- Metabolic Syndrome or Diabetes Mellitus
- Black ethnicity
- Hispanic ethnicity
- Snoring or other findings of Obstructive Sleep Apnea
- Chronic Kidney Disease
- Male gender
- Low birth weight
- Maternal Tobacco use during pregnancy
-
Family History
- Essential Hypertension
- Renovascular disease
- Endocrinopathy
- Diabetes Mellitus
- Thyroid disorder
- Adrenal disease
VI. Associated Conditions
VII. History
- See Family History above
- See Medication Causes of Hypertension (includes OTC Medications and Illicit Drugs)
-
General
- Weight change
- Disordered sleep (e.g. Obstructive Sleep Apnea)
-
Lung
- Dyspnea on exertion
- Cardiovascular
- Renal
- Extremities
- Edema
- Joint Pain or swelling
- Myalgias
- Neurologic
- Endocrine
- Profuse sweating
- Hot or cold intollerance
VIII. Examination: Secondary Hypertension clues
- General
- Eyes
- Fundoscopic exam
- Throat
- Tonsil or adenoid hypertrophy (Sleep Apnea)
- Neck
- Thyromegaly (Hyperthyroidism)
- Cardiovascular
- Tachycardia (Hyperthyroidism, Pheochromocytoma)
- Blood Pressure in both arms while seated and in one leg while prone (Aortic Coarctation)
-
Abdomen
- Abdominal mass (renal lesion)
- Abdominal bruit (Renal Artery Stenosis)
- Genitourinary exam
- Extremities
- Cold legs with diminished pulses (Aortic Coarctation)
- Joint Swelling (Systemic Lupus Erythematosus)
- Skin
- Acne Vulgaris, Hirsutism (Cushing's Disease)
- Malar Rash (Systemic Lupus Erythematosus)
- Profuse sweating (Pheochromocytoma)
- Neurologic
- Proximal Motor weakness (Hyperaldosteronism)
- Endocrine
- Truncal Obesity, moon facies (Cushing's Syndrome)
IX. Diagnosis
- See Hypertension Criteria
- See Blood Pressure for proper technique
- Routine Blood Pressure screening over age 3 years
- Obtain 3 elevated Blood Pressures on different days
- Consider Ambulatory Blood Pressure Monitoring (more accurate than clinic Blood Pressures)
- Hypertension if BP >95% for age, gender, height OR >130/80 if age >13 years old
X. Labs
-
Complete Blood Count
- Includes Leukocyte differential and Platelet Count
- Chemistry panel
- Urine testing
- Urinalysis
- Urine Drug Screen (if indicated)
- Urine Culture
- Consider Urine Microalbumin
- Endocrine tests
- Thyroid Stimulating Hormone (TSH)
- Consider 24 hour Urine Cortisol
- Consider plasma renin level
- Consider 24 hour Urine VMA and metanephrines
- Other Cardiovascular Risk screening
- Lipid Profile
- Secondary Hypertension Evaluation indications (see endocrine tests above)
- Hypertension in age <6 years
- Hypertension in age > 6 years old and other risk factors
- Not Overweight or obese
- No Family HistoryHypertension
- Abnormal history or exam
- Signs or symptoms or specific Secondary Hypertension
XI. Diagnostics
- Electrocardiogram
-
Echocardiogram
- Obtain in all children with confirmed Hypertension
- Renal Ultrasound indications
- Age <6 years old with Hypertension
- Children with abnormal Renal Function test or Urinalysis
- Other studies to consider
- Sleep Study or Polysomnogram (if Sleep Apnea suspected)
- MRA of renal arteries
XII. Screening
- Children and adolescents at no increased Hypertension risk
- Start at age 3 years old and screen every year (AAP 2017) to every 2 years (European Society Hypertension 2016)
- Other organizations (USPTF and AAFP, 2013) have cited insufficient evidence for recommendations
- Children with Hypertension risk factors (see above, or known Secondary Hypertension cause)
- Screen for Hypertension at every healthcare visit starting at time of known risk (regardless of age)
XIII. Management: Non-Pharmacologic Lifestyle Changes
- Involve the entire family in lifestyle changes
- Mnemonic: 5-2-1-0
- Five fruits and vegetables per day
- Maximum of 2 hours per day Screen Time daily
- One hour or more of Physical Activity daily
- No sugary drinks
- Continue monitoring Blood Pressure at least every 6 months
- Home Blood Pressure Monitoring with properly sized cuff and proper technique
- Evaluate for Obesity
- Consider secondary Hypertension Evaluation if weight is normal
- Weight loss if Overweight
- Target 5-10% in a year OR
- Maintain current weight without gaining weight despite increased linear growth
- Evaluate Cardiovascular Risks
-
Cardiovascular Risk management
- Regular Exercise program of 30-60 minutes on most days
- Limit sedentary activities to <2 hours per day
- Low Fat Diet
- Low Sodium Diet (e.g. DASH Diet)
- Fruits and vegetables at least 5 daily
- Tobacco Cessation
- Avoid Alcohol
XIV. Management: Pharmacologic
- Indications
- Symptomatic Hypertension (e.g. Headaches, cognitive changes)
- Secondary Hypertension
- Stage 1 Hypertension refractory to general measures (for at least 3-6 months)
- Or no significant modifiable risk factors (e.g. Obesity, sedentary lifestyle)
- Stage 2 Hypertension
- Significant comorbidity
- End-organ involvement
- Goal Blood Pressures
- Less than 90% for age, height, gender if age <13 years old or
- Less than 130/80 if age >13 years old
- Agents FDA approved in children
- Approach
- Start at the lowest recommended dose and titrate every 2-4 weeks until at target BP
- Initiate a second medication if goal not reached despite maximal dose of first medication
- Special Indications
- See Hypertension Management for Specific Populations
- Diabetes Mellitus or Kidney disease
- ACE Inhibitors
- Angiotensin Receptor Blockers (ARB agents)
- Teen girls at risk for pregnancy (avoiding Teratogenic agents)
- ACE Inhibitors (age 6 and over unless otherwise specified)
- Captopril
- Infant: 0.05 mg/kg/dose every 6 hours (max: 6 mg/kg/day)
- Child: 0.5 mg/kg/dose every 8 hours (max: 6 mg/kg/day)
- Lisinopril 0.07 mg/kg/day up to 5 mg daily (max: 0.6/mg/kg up to 40 mg/day)
- Benazepril (Lotensin) 0.2 mg/kg up to 10 mg (max: 0.6 mg/kg up to 40 mg/day)
- Enalapril (Vasotec) 0.08 mg/kg up to 5 mg (max: 0.6 mg/kg up to 40 mg/day)
- Has been used in age >1 month of age
- Fosinopril (Monopril)
- Weight >50 kg (111 lb): 5-10 mg daily (max: 40 mg day)
- Weight <50 kg (111 lb): 0.1 mg/kg/day up to 5 mg
- Ramipril 1.6 mg/m2 once daily (max: 6 mg/m2/day)
- Captopril
- Angiotensin Receptor Blockers (age 6 and over, unless otherwise specified)
- Losartan 0.7 mg/kg/day (max: 1.4 mg/kg or 100 mg daily)
- Irbesartan (Avapro) 75 to 150 mg daily for ages 6 to 12 years old
- Use adult dosing for age 13 and over
- Valsartan (Diovan) 1.3 mg/kg/day up to 40 mg/day (max: 2.7 mg/kg/day up to 160 mg/day)
- Olmesartan
- Age >6 and <35 kg (77 lb): 10 mg (max: 20 mg)
- Age >6 and <35 kg (77 lb): 20 mg (max: 40 mg)
- Candesartan
- Age 1-5 y: 0.02 mg/kg/day up to 4 mg/day (max: 0.4 mg/kg/day up to 16 mg/day)
- Age >6 y and <50 kg (111 lb): 4 mg/day (max: 16 mg/day)
- Age >6 y and >50 kg (111 lb): 8 mg/day (max: 32 mg/day)
- Calcium Channel Blockers
- Amlodipine
- Age 1-5 y: 0.1 mg/kg daily (max: 0.6 mg/kg/day up to 5 mg/day)
- Age >6 y: 2.5 to 5 mg/day (max: 10 mg/day)
- Felodipine 2.5 mg/day (max: 10 mg/day) if age 6 years old or older
- Nifedipine XR 0.2 to 0.5 mg/kg/day (max: 3 mg/kg up to 120 mg/day)
- Amlodipine
- Beta Blockers (age 6 years old and over)
- Use other agents first-line, unless other indications (e.g. Migraine Prophylaxis)
- Propranolol 1-2 mg/kg/day (max: 4 mg/kg or 640 mg/day)
- Metoprolol XL 1 mg/kg up to 50 mg (max: 2 mg/kg or 200 mg/day)
- Thiazide Diuretics
- Hydrochlorothiazide 1 mg/kg/day (max: 2 mg/kg/day or 37.5 mg/day)
- Chlorthalidone 0.3 mg/kg (max: 2 mg/kg/day up to 50 mg/day)
- Miscellaneous: Second-line agents
- Approach
XV. Complications
-
Left Ventricular Hypertrophy
- May present as early as childhood
- Cardiovascular disease
- Premature onset in young adults
-
Peripheral Vascular Disease
- Carotid intima-media thickness increase
XVI. References
- (2023) Presc Lett 30(7): 41-2
- (2017) Presc Lett 24(10):57
- (2004) Pediatrics 114:555-76 [PubMed]
- Bartosh (1999) Pediatr Clin North Am 46:235-52 [PubMed]
- Flynn (2005) Adolesc Med Clin 16:11-29 [PubMed]
- Flynn (2017) Pediatrics 140(3): e20171904 [PubMed]
- Luma (2006) Am Fam Physician 73(9):1558-66 [PubMed]
- Riley (2012) Am Fam Physician 85(7): 693-700 [PubMed]
- Riley (2018) Am Fam Physician 98(8): 486-94 [PubMed]